Respiratory Infections News

A study found that older and immunosuppressed patients are at an increased risk for influenza vaccine failure and influenza complications, researchers reported.

Anaphylaxis was rarely reported among the first 4 million recipients of the second COVID-19 vaccine authorized for use in the United States, the CDC and FDA reported in MMWR.

The COVID-19 pandemic may wipe out life expectancy gains that took more than a dozen years for the United States to achieve, according to researchers.

CDC researchers reported recently that a more highly transmissible SARS-CoV-2 variant first detected in the United Kingdom could soon become the dominant variant in the United States, potentially complicating the U.S. response.

I chose a career in infectious diseases during my residency in Detroit.

Days before he was inaugurated, U.S. President Joseph R. Biden Jr. laid out his COVID-19 vaccination plan, which calls for more vaccination centers to be created and federally supported with help from FEMA and the National Guard.

Upper respiratory tract viral load could be used to identify patients with COVID-19 who are at higher risk for severe outcomes, according to findings from a study conducted in Greece.

Influenza vaccine effectiveness was significantly lower among immunocompromised adults compared with nonimmunocompromised adults during the severe 2017-2018 influenza season, according to a study.

COVID-19 lockdowns in several cities affected air pollution less than expected, according to a study published in Science.

Recruitment for the convalescent plasma arm of the RECOVERY trial was closed after an independent board determined there was no evidence the treatment benefited patients with COVID-19, according to the trial’s chief investigators.